Alethia BioTherapeutics Company

Alethia BioTherapeutics is a biotechnology company developing monoclonal antibody-based therapeutics for cancer-associated diseases.
Industry: Genomic and Epigenominc Instabillity
Headquarters: Canada
Founded Date: 2002-01-01
Estimated Revenue: $1M to $10M

Visit Website
Register and Claim Ownership